Abstract:One challenge in the current drug development process is that many newly discovered drug candidates are increasingly insoluble. The use of co-crystals as a solid form technology for enhancing physicochemical properties has grown in popularity within the pharmaceutical industry. The considerable number of molecules that could potentially be used as coformers presents a challenge in the experimental screening and confirmation of each candidate on a routine basis. The use of computational techniques, which can assist in identifying suitable solvents and coformers to form novel co-crystals to improve solubility, stability, and bioavailability of the active pharmaceutical ingredients (API), may offer a viable solution to this issue. In this work, we have applied the COSMO-RS (COnductor-like Screening MOdel for Realistic Solvents) method to computationally identify appropriate solvents and viable coformer candidates for caffeine – a case study in coformer screening. Three distinct COSMO-RS implementations have been employed in solvent and co-crystal screening, and the accuracy of each implementation was scrutinized. In parallel, a quantitative structure–activity relationship (QSAR) model has been developed using machine learning (ML) algorithms to screen caffeine coformers based on their molecular descriptors. Random forest (RF), support vector machine (SVM), and deep neural network (DNN) ML models were considered. Through this work, we have compared various COSMO-RS and ML approaches, finding that the COSMO-RS was more predictive of co-crystal formation than the ML models pursued in this study. The predictions from this screening have led to successful synthesis of two previously unreported caffeine co-crystals with each of pyrogallol and phosphoric acid. We anticipate that the findings in this work will be useful for reducing cost and search space in discovery of new co-crystal materials.

Evaluating experimental, knowledge-based and computational cocrystal screening methods to advance drug-drug cocrystal fixed-dose combination development

Pharmaceutical Cocrystals: A Novel Systematic Approach for the Administration of Existing Drugs in New Crystalline Form

How Many Cocrystals Are We Missing? Assessing Two Crystal Engineering Approaches to Pharmaceutical Cocrystal Screening

A Review to Find Efficient, Cost-Effective, and User-Friendly Approaches

Pharmaceutical cocrystal: a game changing approach for the administration of old drugs in new crystalline form

Efficient Screening of Coformers for Active Pharmaceutical Ingredient Cocrystallization

Pharmaceutical Cocrystals: An Emerging Approach to Modulate Physicochemical Properties of Active Pharmaceutical Ingredients

Pharmaceutical cocrystals: along the path to improved medicines.

Computational screening for prediction of co-crystals: method comparison and experimental validation

Cocrystal and Its Application in the Field of Active Pharmaceutical Ingredients and Food Ingredients.

Cocrystal: A Review on the Design and Preparation of Pharmaceutical Cocrystals

Recent Advances on the Biological Study of Pharmaceutical Cocrystals

Conformation, Virtual Cocrystal Screening, Synthesis and Determination of Dipyridamole

Pharmaceutical Cocrystals: A Perspective on Development and Scale-up of Solution Cocrystallization

Pharmaceutical cocrystal and their role in improving solid state properties of active pharmaceutical ingredients

Pharmaceutical Cocrystals: Molecules, Crystals, Formulations, Medicines

Bioavailability-Enhancing Cocrystals: Screening, In Vivo Predictive Dissolution, and Supersaturation Maintenance

Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications

Efficient Screening of Pharmaceutical Cocrystals by Microspacing In-Air Sublimation.

Mitigating Drug Stability Challenges Through Cocrystallization

Screening technologies of pharmaceutical cocrystals:research advances